CL-218,872

CL-218,872 (CL 218872, CL-218872) is a sedative drug that also has a hypnotic effect. This substance is a non-benzodiazepine and has a different chemical structure, but the effect of exposure is comparable to the benzodiazepine preparation triazolam.

Pharmacology
CL-218,872 is a GABAA receptor agonist, is selective for the α1 subtype and causes a number of effects, such as sedative, anxiolytic, anticonvulsant, amnesic, hypnotic. This substance acts to a greater extent as a strong hypnotic, as studies on mice have shown.

Technical Information:

Product Name: CL-218,872
Other Name(s): CL 218872, CL-218872
IUPAC Name: 3-methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine
CAS: 66548-69-4
Molar Mass: 278.23 g/mol
Molecular Formula: C13H9F3N4
InChi Code: InChI=1S/C13H9F3N4/c1-8-17-18-12-6-5-11(19-20(8)12)9-3-2-4-10(7-9)13(14,15)16/h2-7H,1H3
InChIKey: GUOQUXNJZHGPQF-UHFFFAOYSA-N
Canonical SMILES: CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)C(F)(F)F
Formulation: A crystalline solid
NMR CL-218,872

Create a preliminary purchase request. Check stock availability. Communication with support:
Name *Email *Subject *Message MessageSubmit